Commonwealth Equity Services LLC Grows Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Commonwealth Equity Services LLC raised its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 49.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 245,476 shares of the company’s stock after buying an additional 81,552 shares during the period. Commonwealth Equity Services LLC owned 0.05% of GE HealthCare Technologies worth $19,191,000 as of its most recent filing with the SEC.

Other hedge funds have also recently modified their holdings of the company. D1 Capital Partners L.P. purchased a new stake in GE HealthCare Technologies during the third quarter worth about $268,159,000. Van ECK Associates Corp grew its stake in shares of GE HealthCare Technologies by 107.3% during the 4th quarter. Van ECK Associates Corp now owns 4,841,652 shares of the company’s stock worth $378,520,000 after acquiring an additional 2,506,417 shares during the period. State Street Corp increased its holdings in GE HealthCare Technologies by 7.8% in the 3rd quarter. State Street Corp now owns 18,615,890 shares of the company’s stock worth $1,747,101,000 after acquiring an additional 1,347,114 shares during the last quarter. Massachusetts Financial Services Co. MA purchased a new position in shares of GE HealthCare Technologies in the third quarter worth about $93,713,000. Finally, Jennison Associates LLC raised its position in shares of GE HealthCare Technologies by 124.5% in the fourth quarter. Jennison Associates LLC now owns 1,709,635 shares of the company’s stock valued at $133,659,000 after purchasing an additional 948,017 shares during the period. Institutional investors own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. The Goldman Sachs Group raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and boosted their target price for the company from $85.00 to $100.00 in a report on Tuesday, March 11th. Citigroup raised their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, February 13th. Wells Fargo & Company increased their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. Finally, Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price target for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and a consensus price target of $98.75.

GE HealthCare Technologies Trading Up 0.6 %

GEHC stock opened at $81.97 on Monday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. GE HealthCare Technologies Inc. has a one year low of $74.51 and a one year high of $94.80. The company’s 50 day moving average price is $87.26 and its two-hundred day moving average price is $86.13. The company has a market capitalization of $37.48 billion, a PE ratio of 18.93, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The firm had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.33 billion. As a group, analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.